HEADER HYDROLASE/HYDROLASE INHIBITOR 26-MAY-21 7N13 TITLE CRYSTAL STRUCTURE OF MTH1 IN COMPLEX WITH COMPOUND 32 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 2-HYDROXY-DATP DIPHOSPHATASE,8-OXO-DGTPASE,NUCLEOSIDE COMPND 5 DIPHOSPHATE-LINKED MOIETY X MOTIF 1,NUDIX MOTIF 1; COMPND 6 EC: 3.6.1.55,3.6.1.56; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NUDT1, MTH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.J.ERON REVDAT 3 18-OCT-23 7N13 1 JRNL REVDAT 2 12-JAN-22 7N13 1 JRNL REVDAT 1 03-NOV-21 7N13 0 JRNL AUTH G.K.VEITS,C.S.HENDERSON,A.VOGELAAR,S.J.ERON,L.LEE,A.HART, JRNL AUTH 2 R.W.DEIBLER,J.BADDOUR,W.A.ELAM,R.V.AGAFONOV,J.FREDA, JRNL AUTH 3 P.CHATURVEDI,B.LADD,M.W.CARLSON,H.U.VORA,T.G.SCOTT,T.TIEU, JRNL AUTH 4 A.JAIN,C.L.CHEN,E.S.KIBBLER,M.S.POP,M.HE,G.KERN,H.J.MAPLE, JRNL AUTH 5 G.P.MARSH,M.C.NORLEY,C.S.OAKES,J.A.HENDERSON,M.E.SOWA, JRNL AUTH 6 A.J.PHILLIPS,D.A.PROIA,E.S.PARK,J.S.PATEL,S.L.FISHER, JRNL AUTH 7 C.G.NASVESCHUK,R.ZEID JRNL TITL DEVELOPMENT OF AN ACHILLESTAG DEGRADATION SYSTEM AND ITS JRNL TITL 2 APPLICATION TO CONTROL CAR-T ACTIVITY JRNL REF CURR RES CHEM BIOL V. 1 00010 2021 JRNL REFN ESSN 2666-2469 JRNL DOI 10.1016/J.CRCHBI.2021.100010 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 43523 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.041 REMARK 3 FREE R VALUE TEST SET COUNT : 2194 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.59 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.63 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2985 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.3520 REMARK 3 BIN FREE R VALUE SET COUNT : 169 REMARK 3 BIN FREE R VALUE : 0.4470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2508 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 302 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.08000 REMARK 3 B22 (A**2) : -0.35400 REMARK 3 B33 (A**2) : 1.43300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.109 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.111 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.092 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.798 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.929 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2765 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2543 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3764 ; 1.371 ; 1.637 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5873 ; 1.327 ; 1.615 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 332 ; 8.339 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 151 ;31.639 ;22.583 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 468 ;14.719 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;10.900 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 321 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3153 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 676 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 469 ; 0.193 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 32 ; 0.149 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1236 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 204 ; 0.186 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1272 ; 1.679 ; 1.617 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1273 ; 1.678 ; 1.619 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1600 ; 2.629 ; 2.426 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1599 ; 2.629 ; 2.422 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1493 ; 2.616 ; 1.938 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1470 ; 2.566 ; 1.891 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2149 ; 4.086 ; 2.792 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2114 ; 4.025 ; 2.715 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 3 A 155 1 REMARK 3 1 B 3 B 155 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7N13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1000257158. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9677 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43865 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 51.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5ANV REMARK 200 REMARK 200 REMARK: LONG NEEDLES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23% (W/V) PEG 6K, 200 MM LITHIUM REMARK 280 SULFATE, 100 MM SODIUM ACETATE PH 3.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.80350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.53050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.91750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.53050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.80350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.91750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 100 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 89 -60.23 -107.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7N03 RELATED DB: PDB REMARK 900 7N03 CONTAINS THE SAME PROTEIN COMPLEXED TO A RELATED INHIBITOR. REMARK 900 BOTH ENTRIES BELONG TO THE SAME PUBLICATION. DBREF 7N13 A 1 156 UNP P36639 8ODP_HUMAN 42 197 DBREF 7N13 B 1 156 UNP P36639 8ODP_HUMAN 42 197 SEQADV 7N13 GLY A -1 UNP P36639 EXPRESSION TAG SEQADV 7N13 SER A 0 UNP P36639 EXPRESSION TAG SEQADV 7N13 GLY B -1 UNP P36639 EXPRESSION TAG SEQADV 7N13 SER B 0 UNP P36639 EXPRESSION TAG SEQRES 1 A 158 GLY SER MET GLY ALA SER ARG LEU TYR THR LEU VAL LEU SEQRES 2 A 158 VAL LEU GLN PRO GLN ARG VAL LEU LEU GLY MET LYS LYS SEQRES 3 A 158 ARG GLY PHE GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY SEQRES 4 A 158 LYS VAL GLN GLU GLY GLU THR ILE GLU ASP GLY ALA ARG SEQRES 5 A 158 ARG GLU LEU GLN GLU GLU SER GLY LEU THR VAL ASP ALA SEQRES 6 A 158 LEU HIS LYS VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY SEQRES 7 A 158 GLU PRO GLU LEU MET ASP VAL HIS VAL PHE CYS THR ASP SEQRES 8 A 158 SER ILE GLN GLY THR PRO VAL GLU SER ASP GLU MET ARG SEQRES 9 A 158 PRO CYS TRP PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP SEQRES 10 A 158 MET TRP PRO ASP ASP SER TYR TRP PHE PRO LEU LEU LEU SEQRES 11 A 158 GLN LYS LYS LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY SEQRES 12 A 158 GLN ASP THR ILE LEU ASP TYR THR LEU ARG GLU VAL ASP SEQRES 13 A 158 THR VAL SEQRES 1 B 158 GLY SER MET GLY ALA SER ARG LEU TYR THR LEU VAL LEU SEQRES 2 B 158 VAL LEU GLN PRO GLN ARG VAL LEU LEU GLY MET LYS LYS SEQRES 3 B 158 ARG GLY PHE GLY ALA GLY ARG TRP ASN GLY PHE GLY GLY SEQRES 4 B 158 LYS VAL GLN GLU GLY GLU THR ILE GLU ASP GLY ALA ARG SEQRES 5 B 158 ARG GLU LEU GLN GLU GLU SER GLY LEU THR VAL ASP ALA SEQRES 6 B 158 LEU HIS LYS VAL GLY GLN ILE VAL PHE GLU PHE VAL GLY SEQRES 7 B 158 GLU PRO GLU LEU MET ASP VAL HIS VAL PHE CYS THR ASP SEQRES 8 B 158 SER ILE GLN GLY THR PRO VAL GLU SER ASP GLU MET ARG SEQRES 9 B 158 PRO CYS TRP PHE GLN LEU ASP GLN ILE PRO PHE LYS ASP SEQRES 10 B 158 MET TRP PRO ASP ASP SER TYR TRP PHE PRO LEU LEU LEU SEQRES 11 B 158 GLN LYS LYS LYS PHE HIS GLY TYR PHE LYS PHE GLN GLY SEQRES 12 B 158 GLN ASP THR ILE LEU ASP TYR THR LEU ARG GLU VAL ASP SEQRES 13 B 158 THR VAL HET ZRV A 201 38 HET SO4 A 202 5 HET SO4 A 203 5 HET ZRV B 201 38 HET SO4 B 202 5 HET SO4 B 203 5 HET SO4 B 204 5 HET SO4 B 205 5 HETNAM ZRV 4-ANILINO-6-[4-(BUTYLCARBAMOYL)-3-FLUOROPHENYL]-N- HETNAM 2 ZRV CYCLOPROPYL-7-FLUOROQUINOLINE-3-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 3 ZRV 2(C30 H28 F2 N4 O2) FORMUL 4 SO4 6(O4 S 2-) FORMUL 11 HOH *302(H2 O) HELIX 1 AA1 THR A 44 GLY A 58 1 15 HELIX 2 AA2 PRO A 112 MET A 116 5 5 HELIX 3 AA3 TRP A 117 PRO A 118 5 2 HELIX 4 AA4 ASP A 119 GLN A 129 1 11 HELIX 5 AA5 THR B 44 GLY B 58 1 15 HELIX 6 AA6 ASP B 109 ILE B 111 5 3 HELIX 7 AA7 PRO B 112 MET B 116 5 5 HELIX 8 AA8 TRP B 117 PRO B 118 5 2 HELIX 9 AA9 ASP B 119 GLN B 129 1 11 SHEET 1 AA113 PHE A 35 LYS A 38 0 SHEET 2 AA113 SER A 4 GLN A 14 -1 N VAL A 10 O PHE A 35 SHEET 3 AA113 LEU A 80 THR A 88 1 O ASP A 82 N ARG A 5 SHEET 4 AA113 HIS A 65 PHE A 74 -1 N HIS A 65 O CYS A 87 SHEET 5 AA113 PHE A 133 GLN A 140 1 O PHE A 139 N GLU A 73 SHEET 6 AA113 THR A 144 GLU A 152 -1 O LEU A 146 N LYS A 138 SHEET 7 AA113 THR B 144 VAL B 153 1 O GLU B 152 N LEU A 150 SHEET 8 AA113 LYS B 132 GLN B 140 -1 N LYS B 138 O LEU B 146 SHEET 9 AA113 HIS B 65 PHE B 74 1 N GLU B 73 O PHE B 139 SHEET 10 AA113 LEU B 80 THR B 88 -1 O CYS B 87 N HIS B 65 SHEET 11 AA113 SER B 4 LEU B 13 1 N ARG B 5 O ASP B 82 SHEET 12 AA113 ARG B 17 LYS B 23 -1 O LEU B 19 N VAL B 12 SHEET 13 AA113 TRP B 32 ASN B 33 -1 O ASN B 33 N GLY B 21 SHEET 1 AA2 4 PHE A 35 LYS A 38 0 SHEET 2 AA2 4 SER A 4 GLN A 14 -1 N VAL A 10 O PHE A 35 SHEET 3 AA2 4 ARG A 17 LYS A 23 -1 O ARG A 17 N GLN A 14 SHEET 4 AA2 4 TRP A 32 ASN A 33 -1 O ASN A 33 N GLY A 21 SHEET 1 AA3 4 PHE A 35 LYS A 38 0 SHEET 2 AA3 4 SER A 4 GLN A 14 -1 N VAL A 10 O PHE A 35 SHEET 3 AA3 4 ARG A 17 LYS A 23 -1 O ARG A 17 N GLN A 14 SHEET 4 AA3 4 MET A 101 GLN A 107 -1 O CYS A 104 N LEU A 20 SHEET 1 AA4 4 PHE B 35 LYS B 38 0 SHEET 2 AA4 4 SER B 4 LEU B 13 -1 N VAL B 10 O PHE B 35 SHEET 3 AA4 4 ARG B 17 LYS B 23 -1 O LEU B 19 N VAL B 12 SHEET 4 AA4 4 TRP B 32 ASN B 33 -1 O ASN B 33 N GLY B 21 SHEET 1 AA5 3 MET B 101 GLN B 107 0 SHEET 2 AA5 3 ARG B 17 LYS B 23 -1 N LEU B 20 O CYS B 104 SHEET 3 AA5 3 TRP B 32 ASN B 33 -1 O ASN B 33 N GLY B 21 SHEET 1 AA6 2 THR A 60 VAL A 61 0 SHEET 2 AA6 2 ILE A 91 GLN A 92 -1 O GLN A 92 N THR A 60 CRYST1 59.607 67.835 79.061 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016777 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014742 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012648 0.00000